Cambiar Investors’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40,665	Closed	-$6.12M	–	153
2025 Q1	$6.12M	Buy	40,665 +615	+2%	+$103K	0.26%	90
2024 Q4	$7.39M	Sell	40,050 -5,880	-13%	-$1.13M	0.29%	87
2024 Q3	$9.05M	Buy	45,930 +494	+1%	+$103K	0.35%	85
2024 Q2	$9.39M	Buy	45,436 +316	+0.7%	+$71.6K	0.37%	84
2024 Q1	$12.2M	Sell	45,120 -15,093	-25%	-$3.6M	0.46%	74
2023 Q4	$14.2M	Buy	60,213 +9,651	+19%	+$1.9M	0.56%	56
2023 Q3	$9.91M	Buy	50,562 +1,811	+4%	+$372K	0.42%	79
2023 Q2	$10.2M	Buy	48,751 +5,664	+13%	+$1.13M	0.43%	76
2023 Q1	$8.7M	Buy	43,087 +8,607	+25%	+$1.95M	0.37%	81
2022 Q4	$7.51M	Buy	34,480 +2,387	+7%	+$521K	0.34%	83
2022 Q3	$6.32M	Buy	32,093 +948	+3%	+$205K	0.32%	81
2022 Q2	$6.66M	Sell	31,145 -355	-1%	-$86.7K	0.3%	82
2022 Q1	$8.95M	Buy	+31,500	New	+$9.71M	0.34%	74
2021 Q2	–	Sell	-22,661	Closed	-$6.57M	–	150
2021 Q1	$6.57M	Buy	22,661 +2,919	+15%	+$811K	0.23%	89
2020 Q4	$4.93M	Sell	19,742 -4,537	-19%	-$1.08M	0.19%	86
2020 Q3	$5.5M	Sell	24,279 -3,076	-11%	-$638K	0.25%	68
2020 Q2	$4.77M	Sell	27,355 -5,110	-16%	-$816K	0.22%	72
2020 Q1	$4.1M	Buy	+32,465	New	+$4.87M	0.21%	67